Takeda’s Maribavir For Post-Transplant Cytomegalovirus Might See Split Panel Vote

 
• By Sue Sutter
  
Cytomegalovirus
Cytomegalovirus is a common cause of infection in post-transplant recipients. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers